TheraLight Inc., a privately held developer of light-based medical instruments, said on
Tuesday that it received clearance from the US Food and Drug Administration (FDA) to market its UV120-2 UVA/UVB phototherapy system for the treatment of psoriasis, vitiligo, and atopic and seborrheic dermatitis.
השאירו תגובה
רוצה להצטרף לדיון?תרגישו חופשי לתרום!